FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890354015> ?p ?o ?g. }

• W2890354015 endingPage "587" @default.
• W2890354015 startingPage "578" @default.
• W2890354015 abstract "Long term outcomes and mutations in patients with mantle cell lymphoma (MCL) who discontinued ibrutinib have not been described. Using deep targeted next generation sequencing, we performed somatic mutation profiling from 15 MCL patients (including 5 patients with paired samples; before and after progression on ibrutinib). We identified 80 patients with MCL who discontinued ibrutinib therapy for various reasons. Median follow-up after ibrutinib discontinuation was 38 months. The median duration on ibrutinib was 7·6 months. Forty-one (51%) patients discontinued ibrutinib due to disease progression/transformation, 20 (25%) for intolerance, 7 (9%) due to patient choice, 5 (6%) for stem cell transplant, 4 (5%) due to second cancers and 3 (4%) other causes. The median survival after ibrutinib was 10 and 6 months for disease progression and transformation, respectively, and 25 months for patients with ibrutinib intolerance. Overall, BTK mutations were observed in 17% patients after progression on ibrutinib. Notably, TP53 alterations were observed after progression in 75% patients. Among the 4 patients with blastoid transformation, 3 (75%) had NSD2 mutations (co-existing with TP53). Ibrutinib-refractory MCL patients had a short survival. Demonstration of TP53 and NSD2 mutations in patients who developed blastoid transformation and ATM and TP53 mutations in patients who progressed, opens the door for future investigations in ibrutinib-refractory MCL." @default.
• W2890354015 created "2018-09-27" @default.
• W2890354015 creator A5000027373 @default.
• W2890354015 creator A5003905836 @default.
• W2890354015 creator A5004970562 @default.
• W2890354015 creator A5008617175 @default.
• W2890354015 creator A5014007447 @default.
• W2890354015 creator A5015633466 @default.
• W2890354015 creator A5020588158 @default.
• W2890354015 creator A5027450560 @default.
• W2890354015 creator A5038345056 @default.
• W2890354015 creator A5044284041 @default.
• W2890354015 creator A5048913229 @default.
• W2890354015 creator A5051182441 @default.
• W2890354015 creator A5052021553 @default.
• W2890354015 creator A5053926894 @default.
• W2890354015 creator A5059373442 @default.
• W2890354015 creator A5064752432 @default.
• W2890354015 creator A5065605723 @default.
• W2890354015 creator A5066599847 @default.
• W2890354015 creator A5067916180 @default.
• W2890354015 creator A5081225502 @default.
• W2890354015 creator A5085419504 @default.
• W2890354015 creator A5089736242 @default.
• W2890354015 date "2018-09-02" @default.
• W2890354015 modified "2023-10-17" @default.
• W2890354015 title "Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib" @default.
• W2890354015 cites W1192491316 @default.
• W2890354015 cites W1829587101 @default.
• W2890354015 cites W1977342543 @default.
• W2890354015 cites W1989875808 @default.
• W2890354015 cites W1991899579 @default.
• W2890354015 cites W2024040061 @default.
• W2890354015 cites W2024216962 @default.
• W2890354015 cites W2028681024 @default.
• W2890354015 cites W2031530131 @default.
• W2890354015 cites W2073359527 @default.
• W2890354015 cites W2075088038 @default.
• W2890354015 cites W2107804586 @default.
• W2890354015 cites W2112023756 @default.
• W2890354015 cites W2154066874 @default.
• W2890354015 cites W2160796968 @default.
• W2890354015 cites W2237195636 @default.
• W2890354015 cites W2345102372 @default.
• W2890354015 cites W2407062960 @default.
• W2890354015 cites W2408036343 @default.
• W2890354015 cites W2566053885 @default.
• W2890354015 cites W2575189453 @default.
• W2890354015 cites W2582696216 @default.
• W2890354015 cites W2589238872 @default.
• W2890354015 cites W2606935597 @default.
• W2890354015 cites W2730888200 @default.
• W2890354015 cites W2749289906 @default.
• W2890354015 cites W2773047201 @default.
• W2890354015 cites W2773054919 @default.
• W2890354015 cites W2773946416 @default.
• W2890354015 cites W2774522106 @default.
• W2890354015 cites W2794404663 @default.
• W2890354015 doi "https://doi.org/10.1111/bjh.15567" @default.
• W2890354015 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30175400" @default.
• W2890354015 hasPublicationYear "2018" @default.
• W2890354015 type Work @default.
• W2890354015 sameAs 2890354015 @default.
• W2890354015 citedByCount "73" @default.
• W2890354015 countsByYear W28903540152019 @default.
• W2890354015 countsByYear W28903540152020 @default.
• W2890354015 countsByYear W28903540152021 @default.
• W2890354015 countsByYear W28903540152022 @default.
• W2890354015 countsByYear W28903540152023 @default.
• W2890354015 crossrefType "journal-article" @default.
• W2890354015 hasAuthorship W2890354015A5000027373 @default.
• W2890354015 hasAuthorship W2890354015A5003905836 @default.
• W2890354015 hasAuthorship W2890354015A5004970562 @default.
• W2890354015 hasAuthorship W2890354015A5008617175 @default.
• W2890354015 hasAuthorship W2890354015A5014007447 @default.
• W2890354015 hasAuthorship W2890354015A5015633466 @default.
• W2890354015 hasAuthorship W2890354015A5020588158 @default.
• W2890354015 hasAuthorship W2890354015A5027450560 @default.
• W2890354015 hasAuthorship W2890354015A5038345056 @default.
• W2890354015 hasAuthorship W2890354015A5044284041 @default.
• W2890354015 hasAuthorship W2890354015A5048913229 @default.
• W2890354015 hasAuthorship W2890354015A5051182441 @default.
• W2890354015 hasAuthorship W2890354015A5052021553 @default.
• W2890354015 hasAuthorship W2890354015A5053926894 @default.
• W2890354015 hasAuthorship W2890354015A5059373442 @default.
• W2890354015 hasAuthorship W2890354015A5064752432 @default.
• W2890354015 hasAuthorship W2890354015A5065605723 @default.
• W2890354015 hasAuthorship W2890354015A5066599847 @default.
• W2890354015 hasAuthorship W2890354015A5067916180 @default.
• W2890354015 hasAuthorship W2890354015A5081225502 @default.
• W2890354015 hasAuthorship W2890354015A5085419504 @default.
• W2890354015 hasAuthorship W2890354015A5089736242 @default.
• W2890354015 hasBestOaLocation W28903540151 @default.
• W2890354015 hasConcept C126322002 @default.
• W2890354015 hasConcept C143998085 @default.
• W2890354015 hasConcept C2777525834 @default.
• W2890354015 hasConcept C2777938653 @default.
• W2890354015 hasConcept C2778461978 @default.

• next